Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia

Cancer Genetics and Cytogenetics

Volumn 197, Issue 2, 2010, Pages 117-121

  Bang, Soo Mee ^a   Seo, Ji Weon ^b   Park, Kyung Un ^a   Kim, Seok Jin ^c   Kim, Kihyun ^c   Kim, Sun Hee ^c   Cho, Sung Ran ^d   Kim, Hugh C ^d   Song, Jaewoo ^e   Kim, Jin Seok ^e   Kim, Kyung Hee ^f   Lee, Jae Hoon ^f   Lee, Je Jung ^g   Shin, Myung Geun ^g   Suh, Cheolwon ^h   Chi, Hyun Sook ^h   Oh, Do yeun ⁱ   Won, Jong Ho ^j   Kim, Hyo Jung ^k   Yoon, Sung Soo ^b   Lee, Dong Soon ^b   more..

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Ajou University School of Medicine   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Gachon University   (South Korea)

^g Chonnam National University Research Institute of Medical Sciences   (South Korea)

^h University of Ulsan College of Medicine   (South Korea)

ⁱ CHA University   (South Korea)

^j Soonchunhyang University College of Medicine   (South Korea)

^k Hallym University Medical Center   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME 4; CHROMOSOME 9; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; KARYOTYPE; KOREA; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; TRISOMY; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 6; COHORT STUDIES; FEMALE; GENE DELETION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; KOREA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; WALDENSTROM MACROGLOBULINEMIA;

EID: 77449092301     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.008     Document Type: Article

References (26)

1. Owen R.G., Treon S.P., Al-Katib A., Fonseca R., Greipp P.R., McMaster M.L., Morra E., Pangalis G.A., San Miguel J.F., Branagan A.R., and Dimopoulos M. Clinicopathological definition of Waldenström's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström's Macroglobulinemia. Semin Oncol 30 (2003) 110-115
2. Vijay A., and Gertz M.A. Waldenström macroglobulinemia. Blood 109 (2007) 5096-5103
3. Kyle R.A., and Rajkumar S.V. Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 20 (2007) 637-664
4. Bang S.M., Park S.R., Park S.H., Cho E.K., Yoon S.S., Shin D.B., Lee J.H., Park S., Kim B.K., and Kim N.K. Clinical features of Waldenström macroglobulinemia in Korea. Korean J Intern Med 19 (2004) 137-140
5. Avet-Loiseau H., Garand R., Lode L., Robillard N., and Bataille R. 14q32 translocations discriminate IgM multiple myeloma from Waldenström's macroglobulinemia. Semin Oncol 30 (2003) 153-155
6. Schop R.F., Van Wier S.A., Xu R., Ghobrial I., Ahmann G.J., Greipp P.R., Kyle R.A., Dispenzieri A., Lacy M.Q., Rajkumar S.V., Gertz M.A., and Fonseca R. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet 169 (2006) 150-153
7. Terre C., Nguyen-Khac F., Barin C., Mozziconacci M.J., Eclache V., Leonard C., Chapiro E., Farhat H., Bouyon A., Rousselot P., Choquet S., Spentchian M., Dubreuil P., Leblond V., and Castaigne S. Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 cases. Leukemia 20 (2006) 1634-1636
8. Chang H., Qi X., Xu W., Reader J.C., and Ning Y. Analysis of 6q deletion in Waldenström macroglobulinemia. Eur J Haematol 79 (2007) 244-247
9. Lee J.H., and Bang S.M. Epidemiological change of multiple myeloma in Korea. Korean J Hematol 41 (2006) 225-234
10. Pedersen B., and Kerndrup G. Specific minor chromosome deletions consistently occurring in myelodysplastic syndromes. Cancer Genet Cytogenet 23 (1986) 61-75
11. Mitelman F. International system for human cytogenetic nomenclature (1995), S Karger, Basel
12. Dimopoulos M.A., Kastritis E., Delimpassi S., Zomas A., Kyrtsonis M.C., and Zervas K. The International Prognostic Scoring System for Waldenström's macroglobulinemia is applicable in patients treated with rituximab-based regimens. Haematologica 93 (2008) 1420-1422
13. Aoki H., Takishita M., and Kosaka M. Frequent somatic mutation in D and/or JH segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not common in CLL. Blood 85 (1995) 1913-1919
14. Ivanovski M., Silvestri F., Pozzato G., Anand S., Mazzaro C., Burrone O.R., and Efremov D.G. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91 (1998) 2433-2442
15. Sahota S.S., Garand R., Bataille R., Smith A.J., and Stevenson F.K. VH gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. Blood 91 (1998) 238-243
16. Wagner S., Martinelli V., and Luzzato L. Similar patterns of somatic hypermutation in hairy cell leukemia, prolymphocytic leukaemia. Waldenström's macroglobulinemia and myeloma. Blood 83 (1994) 3647-3653
17. Hallek M., Bergsagel P.L., and Anderson K.C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91 (1998) 3-21
18. Schop R.F., Kuehl W.M., Van Wier S.A., Ahmann G.J., Price-Troska T., Bailey R.J., Jalal S.M., Qi Y., Kyle R.A., Greipp P.R., and Fonseca R. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 100 (2002) 2996-3001
19. Shapiro-Shelef M., Lin K.I., Savitsky D., Liao J., and Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med 202 (2005) 1471-1476
20. Johnson K., Shapiro-Shelef M., Tunyaplin C., and Calame K. Regulatory events in early and late B-cell differentiation. Mol Immunol 42 (2005) 749-761
21. Hagman J., and Lukin K. Transcription factors drive B cell development. Curr Opin Immunol 18 (2006) 127-134
22. Boultwood J., Pellagatti A., Watkins F., Campbell L.J., Esoof N., Cross N.C., Eagleton H., Littlewood T.J., Fidler C., and Wainscoat J.S. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 126 (2004) 508-511
23. Hagiwara K., Nagai H., Li Y., Ohashi H., Hotta T., and Saito H. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma. J Clin Exp Hematop 47 (2007) 15-18
24. Nishii K., Usui E., Katayama N., Lorenzo V F., Nakase K., Kobayashi T., Miwa H., Mizutani M., Tanaka I., Nasu K., Dohy H., Kyo T., Taniwaki M., Ueda T., Kita K., and Shiku H. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia 17 (2003) 731-737
25. Ocio E.M., Schop R.F., Gonzalez B., Van Wier S.A., Hernandez-Rivas J.M., Gutierrez N.C., Garcia-Sanz R., Moro M.J., Aguilera C., Hernandez J., Xu R., Greipp P.R., Dispenzieri A., Jalal S.M., Lacy M.Q., Gonzalez-Paz N., Gertz M.A., San Miguel J.F., and Fonseca R. 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis. Br J Haematol 136 (2007) 80-86
26. Gutiérrez N.C., Ocio E.M., de Las Rivas J., Maiso P., Delgado M., Fermiñán E., Arcos M.J., Sánchez M.L., Hernández J.M., and San Miguel J.F. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 21 (2007) 541-549